HUTCHMED Other Liab from 2010 to 2024

HCM Stock  USD 17.41  0.05  0.29%   
HUTCHMED DRC Other Liabilities yearly trend continues to be very stable with very little volatility. Other Liabilities is likely to drop to about 10.1 M. During the period from 2010 to 2024, HUTCHMED DRC Other Liabilities quarterly data regression pattern had sample variance of 25.5 T and median of  8,299,000. View All Fundamentals
 
Other Liabilities  
First Reported
2013-12-31
Previous Quarter
15.4 M
Current Value
15.4 M
Quarterly Volatility
4.7 M
 
Yuan Drop
 
Covid
Check HUTCHMED DRC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HUTCHMED DRC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.9 M, Interest Expense of 879.4 K or Selling And Marketing Expenses of 31.2 M, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0024 or PTB Ratio of 3.97. HUTCHMED financial statements analysis is a perfect complement when working with HUTCHMED DRC Valuation or Volatility modules.
  
Check out the analysis of HUTCHMED DRC Correlation against competitors.
To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.

Latest HUTCHMED DRC's Other Liab Growth Pattern

Below is the plot of the Other Liab of HUTCHMED DRC over the last few years. It is HUTCHMED DRC's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HUTCHMED DRC's overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

HUTCHMED Other Liab Regression Statistics

Arithmetic Mean8,466,512
Geometric Mean6,835,613
Coefficient Of Variation59.67
Mean Deviation4,011,479
Median8,299,000
Standard Deviation5,051,879
Sample Variance25.5T
Range15.3M
R-Value0.88
Mean Square Error6T
R-Squared0.78
Significance0.000012
Slope999,007
Total Sum of Squares357.3T

HUTCHMED Other Liab History

202410.1 M
202317.7 M
202215.4 M
202114.3 M
202013.3 M
20198.7 M
20187.1 M

About HUTCHMED DRC Financial Statements

HUTCHMED DRC investors utilize fundamental indicators, such as Other Liab, to predict how HUTCHMED Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Other Liabilities17.7 M10.1 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether HUTCHMED DRC is a strong investment it is important to analyze HUTCHMED DRC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact HUTCHMED DRC's future performance. For an informed investment choice regarding HUTCHMED Stock, refer to the following important reports:
Check out the analysis of HUTCHMED DRC Correlation against competitors.
To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.84)
Earnings Share
(0.25)
Revenue Per Share
3.575
Quarterly Revenue Growth
(0.43)
Return On Assets
(0.06)
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.